Clinical and pathological factors of intrahepatic recurrenceafter initial treatment in patients with hepatocelluar carcinoma

WEN Ming; et al

您当前的位置：

首页 >

文章列表页 >

Clinical and pathological factors of intrahepatic recurrenceafter initial treatment in patients with hepatocelluar carcinoma

更新时间：2024-01-17

- Clinical and pathological factors of intrahepatic recurrenceafter initial treatment in patients with hepatocelluar carcinoma
- Journal of Chongqing Medical University Issue 2, Pages: 268-271(2006)
- 作者机构：
  
  1. 重庆医科大学附属第一医院放射科
  2. 重庆市第九人民医院放射肿瘤科
  3. 重庆医科大学基础医学院
  4. 重庆医科大学附属第一医院肝胆外科
  5. 华蓥市广能医院
  6. 重庆钢铁公司职工总医院介入放射科,重庆,400016
  7. ,重庆,400084
- 作者简介：
- 基金信息：
- DOI：
  CLC： R735.7
- Published：2006，
扫描看全文
[1]文明,蒋明东,彭志平,李少林,袁书伟,阎雄,彭云,唐红兵.肝细胞癌治疗后肝内复发的临床病理特征[J].重庆医科大学学报,2006(02):268-271.

WEN Ming, et al. Clinical and pathological factors of intrahepatic recurrenceafter initial treatment in patients with hepatocelluar carcinoma. [J]. Journal of Chongqing Medical University (2):268-271(2006)
[1]文明,蒋明东,彭志平,李少林,袁书伟,阎雄,彭云,唐红兵.肝细胞癌治疗后肝内复发的临床病理特征[J].重庆医科大学学报,2006(02):268-271. DOI：

WEN Ming, et al. Clinical and pathological factors of intrahepatic recurrenceafter initial treatment in patients with hepatocelluar carcinoma. [J]. Journal of Chongqing Medical University (2):268-271(2006) DOI：

摘要

目的:评价肝细胞癌（HCC）治疗后肝内复发的临床病理特征。方法:收集57例病理证实的HCC复发病例

依据复发类型分为多中心发生（MO）和肝内转移（IM）两组

采用单变量和多变量统计学模式

分析临床资料及病理学类型间的关系。结果:HCC治疗后累计复发率分别为1年24.56%、2年47.37%、3年63.16%、4年70.18%、5年75.44%。MO与肝炎病史和AFP浓度密切相关

预后相对较好

而IM组复发与肿瘤细胞分化程度相关

且多在3年内出现。结论:MO和IM肿瘤的发展及生物学行为完全不同

早期发现肝内复发病灶并采取恰当的治疗

可以延长MO患者的生存率。

Abstract

Objective: To investigate the clinical and pathological factors of intrahepatic recurrence after initial treatment in patients with hepatocelluar carcinoma(HCC).Methods: 57 consecutive patients with pathologically proven recurrent HCC were collected.And these cases were classified into two groups: multicentric occurrence(MO) group and intrahepatic metastasis(IM) based on the type of recurrence.The univariate and multivariate analysis were used for the relationship between the clinical datum and pathological types.Results: Overall recurrence rates after initial treatment were 24.56% at 1 year

47.37% at 2 years

63.16% at 3 years

70.18% at 4 years

and 75.44% at 5 years

respectively.MO was closely associated with hepatitis and AFP concentration

and showed better prognoses.While in patients with IM

the lesions related to the degree of tumor cell differentiation and the majority of recurrences were observed within 3 years.Conclusion: The development and biological behaviors of the MO and IM were quite different.Early detection of intrahepatic recurrence and institute appropriate therapy may prolong survival in patients with MO.

关键词

肝细胞癌复发病理

Keywords

hepatocelluar carcinomarecurrencepathology

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Risk factors for the recurrence of craniopharyngioma

Assessment of tumor-associated fibroblast as a biomarker for predicting recurrence of non-muscle invasive bladder cancer

Two therapeutic schemes for Ⅱ degree intrauterine adhesion:a clinical control study

Comparison of endorectal ultrasonography with postoperative pathology of rectal cancer

Clinical and pathologic analysis of 12 cases of leprosy

Related Author

Tian Lihua

Zhong Liyong

Yin Hubin

Li Tinghao

Chen Junrui

Feng Zhenwei

Gou Xin

He Weiyang

Related Institution

Department of Endocrinology，Beijing Tiantan Hospital，Capital Medical University

Department of Urinary Surgery，The First Affiliated Hospital of Chongqing Medical University

Hysteroscopic Center,Fuxing Hospital,Capital Medical University

重庆医科大学临床学院普外科

重庆医科大学临床学院超声诊断室

⁰